期刊
MUCOSAL IMMUNOLOGY
卷 11, 期 4, 页码 1024-1038出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/s41385-018-0019-2
关键词
-
类别
资金
- European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation Programme [ERC-2016-StG-71577]
- JPI HDHL Intestinal Microbiomics [ANR-15-HDIM-0001-1]
- Danone
- MSD
- Takeda
- Abbvie
- Astellas
- Enterome
- Maat
- Novartis
- BMS
- Nextbiotix
- Agence Nationale de la Recherche (ANR) [ANR-15-HDIM-0001] Funding Source: Agence Nationale de la Recherche (ANR)
Aryl hydrocarbon receptor (AhR) is a member of the basic helix-loop-helix-(bHLH) superfamily of transcription factors, which are associated with cellular responses to environmental stimuli, such as xenobiotics and oxygen levels. Unlike other members of bHLH, AhR is the only bHLH transcription factor that is known to be ligand activated. Early AhR studies focused on understanding the role of AhR in mediating the toxicity and carcinogenesis properties of the prototypic ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). In recent years, however, it has become apparent that, in addition to its toxicological involvement, AhR is highly receptive to a wide array of endogenous and exogenous ligands, and that its activation leads to a myriad of key host physiological functions. In this study, we review the current understanding of the functions of AhR in the mucosal immune system with a focus on its role in intestinal barrier function and intestinal immune cells, as well as in intestinal homeostasis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据